Every Form 4 that CACI INTERNATIONAL CLA (CACI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CACI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CACI filings page.
DISBROW LISA S reported acquisition or exercise transactions in this Form 4 filing.
CACI International director Lisa S. Disbrow reported an equity grant of 58 shares of CACI common stock on July 30, 2026, received in connection with her annual retainer as Chair of the Board. After this grant, she directly holds 2,510 shares of CACI common stock.
Director Charles L. Szews exercised 85 Restricted Stock Units into 85 shares of CACI common stock on July 13, 2026. These RSUs are part of a 338-unit grant dated October 16, 2025 with scheduled vesting through October 11, 2026. Following the transaction, Szews holds 584 CACI common shares and 85 RSUs directly.
Director Philip O. Nolan acquired 85 shares of CACI common stock through the vesting and conversion of Restricted Stock Units. This compensation-related transaction involved no open-market buying or selling. Following the transaction, he directly holds 2,322 CACI shares and 85 RSUs from a prior grant of 338 RSUs that vest in four installments.
CACI INTERNATIONAL INC /DE/ director Scott C. Morrison reported the vesting and conversion of 85 Restricted Stock Units into 85 shares of CACI Common Stock on July 13, 2026. These RSUs are part of a 338-unit grant awarded on October 16, 2025, with multiple scheduled vesting dates. Following this event, Morrison holds 584 common shares and 85 RSUs directly.
CACI International Inc. director Sloane Stanton reported a derivative exercise/conversion involving 85 Restricted Stock Units and a corresponding 85-share change in CACI common stock on July 13, 2026. Following the transactions, he holds 1,112 shares of CACI common stock directly and 85 Restricted Stock Units. A prior grant of 338 RSUs, awarded on October 16, 2025, vests in four installments: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026.
CACI International director Lisa S. Disbrow reported the vesting and conversion of 123 Restricted Stock Units into 123 shares of CACI common stock on July 13, 2026. This compensation-related derivative exercise increased her directly held common stock to 2,452 shares.
The RSUs relate to a grant of 492 units made on October 16, 2025, scheduled to vest in four equal installments of 123 shares on January 14, 2026, April 14, 2026, July 13, 2026 and October 11, 2026.
CACI International director Ryan D. McCarthy exercised restricted stock units on July 13, 2026, acquiring 85 shares of CACI common stock through a derivative conversion. After the transaction, he holds 2,322 common shares directly and 85 restricted stock units that are scheduled to vest in a later tranche.
CACI International director Debora A. Plunkett reported the vesting and conversion of 85 Restricted Stock Units into CACI common stock on July 13, 2026. After this derivative exercise, she directly holds 2,597 CACI common shares and retains 85 RSUs from a 338-unit grant awarded on October 16, 2025.
CACI International Inc. director Susan M. Gordon acquired 85 shares of CACI Common Stock on July 13, 2026 through the exercise and conversion of Restricted Stock Units (RSUs), not an open-market purchase. After this vesting event, she directly holds 2,726 common shares and 85 RSUs scheduled to vest on October 11, 2026.
Young David Anthony reported acquisition or exercise transactions in this Form 4 filing.
CACI International executive David Anthony Young, EVP and Chief Operating Officer, received a grant of 4,448 restricted stock units on June 22, 2026. These units represent rights linked to CACI Common Stock and vest in three equal annual installments on June 22, 2027, June 22, 2028 and June 22, 2029.
CACI International director Susan M. Gordon reported an open-market sale of CACI Common Stock. On June 16, she sold 264 shares at a price of $500.38 per share. After this transaction, she directly holds 2,641 shares of CACI Common Stock.
CACI International executive DeEtte Gray, President of US Operations, exercised previously granted equity awards that vested on April 26, 2026. She converted 10,636 restricted stock units into an equal number of CACI common shares and, in a separate step, 4,512 shares were withheld to cover tax obligations at a value of $516.54 per share, rather than sold in the open market. After these transactions, she holds 39,485 CACI common shares directly, reflecting routine compensation-related activity rather than discretionary buying or selling.
DISBROW LISA S reported acquisition or exercise transactions in this Form 4 filing.
CACI International director Lisa S. Disbrow received a grant of 52 shares of CACI common stock on April 16, 2026 as part of her annual retainer for serving as Chair of the Board. This compensation award increased her directly held stake to 2,329 shares.
CACI International director Susan M. Gordon exercised restricted stock units into common shares. On April 14, 2026, she converted 84 Restricted Stock Units into 84 shares of CACI Common Stock, a non-cash derivative exercise.
Following the transaction, she directly held 2,905 shares of CACI Common Stock and 170 Restricted Stock Units. A prior grant on October 17, 2025 awarded 338 RSUs, scheduled to vest in four tranches: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026.
Director Ryan D. McCarthy of CACI International Inc. exercised 84 Restricted Stock Units on April 14, 2026, converting them into 84 shares of CACI Common Stock at an exercise price of $0.00 per share. After this transaction, he directly owns 2,237 shares of CACI Common Stock and 170 Restricted Stock Units. The exercised RSUs are part of a 338-unit grant awarded on October 17, 2025, scheduled to vest in four installments through October 11, 2026. This filing reflects a routine compensation-related derivative exercise rather than an open-market stock purchase or sale.
CACI International director Scott C. Morrison exercised restricted stock units into common shares as part of a scheduled equity award. On April 14, 2026, 84 RSUs converted into 84 shares of CACI Common Stock at a stated price of $0.00 per share, increasing his direct holdings to 499 shares. A prior grant of 338 RSUs made on October 17, 2025 is scheduled to vest in four tranches: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026.
CACI International director Philip O. Nolan exercised restricted stock units into common shares as part of his equity compensation. On April 14, 2026, 84 RSUs converted into 84 shares of CACI common stock at a stated price of $0.00 per share, a non-cash equity award.
Following the transaction, Nolan directly held 2,237 CACI common shares and 170 restricted stock units. The footnote explains these RSUs come from a grant of 338 RSUs on October 17, 2025, vesting in four scheduled tranches through October 2026, indicating this is a routine, pre-set vesting event rather than an open-market trade.
CACI International director Lisa S. Disbrow exercised 123 Restricted Stock Units into 123 shares of CACI common stock on April 14, 2026. This transaction increased her direct common share holdings to 2,277 shares and left 246 Restricted Stock Units outstanding from a 492-unit grant awarded on October 16, 2025.
CACI International director Debora A. Plunkett exercised 84 Restricted Stock Units into 84 shares of CACI common stock at a stated price of $0.00 per share. The RSUs are part of a 338-unit grant awarded on October 17, 2025 with scheduled vesting dates through October 11, 2026. Following this transaction, she holds 2,512 shares of CACI common stock directly and 170 RSUs that remain unvested from the same grant.
CACI International director Charles L. Szews reported an exercise of 84 Restricted Stock Units into CACI common stock. The transaction occurred on April 14, 2026 and increased his directly held common shares to 499.
The 84 RSUs exercised are part of a 338-unit grant awarded on October 17, 2025, vesting in four tranches: 84 shares on January 14, 2026, 84 on April 14, 2026, 85 on July 13, 2026, and 85 on October 11, 2026. This filing reflects a routine compensation-related vesting and share delivery, with no open-market buying or selling.
CACI International director Stanton D. Sloane exercised restricted stock units into common shares as part of a vesting schedule. On April 14, 2026, 84 Restricted Stock Units converted into 84 shares of CACI common stock at an exercise price of $0.00 per share, increasing his direct holdings to 1,027 common shares.
These RSUs come from a grant of 338 units awarded on October 17, 2025, which vests in four installments through October 2026. The transaction reflects routine, compensation-related equity vesting rather than an open-market purchase or sale.
Director Debora A. Plunkett reported an open-market sale of 220 shares of CACI Common Stock on March 11, 2026 at an average price of $603.30 per share. After this transaction, she directly holds 2,428 shares of CACI common stock.
CACI International executive J. William Koegel Jr., EVP and General Counsel, reported an insider stock sale. On February 10, 2026, he executed an open-market sale of 2,000 shares of CACI Common Stock at $615.0625 per share. Following this transaction, he directly owned 25,931 shares of CACI Common Stock.
CACI International director Philip O. Nolan reported the vesting and conversion of 84 Restricted Stock Units into 84 shares of CACI common stock on January 14, 2026. The Form 4 shows this as a transaction with no exercise price. These RSUs are part of a 338-unit grant awarded on October 17, 2025, which is scheduled to vest in four installments through October 11, 2026. After this vesting event, Nolan directly holds 2,153 shares of CACI common stock and 254 RSUs, reflecting his ongoing equity-based compensation as a director.
CACI International director Charles L. Szews reported the vesting of previously granted equity awards. On January 14, 2026, 84 Restricted Stock Units (RSUs) that were granted on October 17, 2025 vested and were converted into 84 shares of CACI common stock at an exercise price of $0.00 per share.
After this transaction, Szews directly owns 415 shares of CACI common stock and 254 RSUs, which are scheduled to vest later under the original grant of 338 RSUs. The remaining RSUs are expected to vest in three additional installments on April 14, 2026, July 13, 2026, and October 11, 2026.
CACI International director Scott C. Morrison reported the vesting and conversion of restricted stock units into common shares. On January 14, 2026, 84 Restricted Stock Units vested and were converted into 84 shares of CACI common stock at a price of $0.00 per share, reported with transaction code "M". After this transaction, Morrison directly owned 415 shares of CACI common stock and 254 Restricted Stock Units. These RSUs are part of a 338-unit grant made on October 17, 2025 that vests in four installments through October 11, 2026.
CACI International director Susan M. Gordon reported a routine equity compensation vesting. On January 14, 2026, 84 Restricted Stock Units (RSUs) previously granted to her converted into CACI common stock at an exercise price of $0 per share. These RSUs are part of a 338-unit grant awarded on October 17, 2025, scheduled to vest in four installments through October 11, 2026.
Following this transaction, Gordon directly beneficially owned 2,821 shares of CACI common stock and 254 RSUs, reflecting ongoing board compensation rather than an open-market purchase or sale.
CACI International director Stanton D. Sloane reported the vesting of 84 Restricted Stock Units (RSUs) into 84 shares of CACI common stock on January 14, 2026, at an exercise price of $0 per share. After this transaction, he beneficially owned 943 shares of CACI common stock and 254 RSUs directly.
These RSUs are part of a 338-unit grant awarded on October 17, 2025, with a scheduled vesting of 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026.
CACI International director Lisa Disbrow reported equity awards tied to her board service. On January 14, 2026, 123 Restricted Stock Units (RSUs) vested and were settled into 123 shares of CACI common stock, leaving her with 2,110 directly held shares and 369 RSUs still outstanding from a 492-unit grant made on October 16, 2025. On January 15, 2026, she received an additional 44 shares of common stock in connection with her annual retainer as Chair of the Board, bringing her direct holdings to 2,154 shares.
CACI International Inc. director Debora A. Plunkett reported the vesting of restricted stock units and corresponding issuance of common shares. On January 14, 2026, 84 Restricted Stock Units converted at an exercise price of $0.0000 per unit into 84 shares of CACI common stock, reported as a transaction with code "M." Following this transaction, she directly held 2,648 shares of CACI common stock and 254 Restricted Stock Units.
The footnote explains that on October 17, 2025, she was granted 338 Restricted Stock Units, scheduled to vest in four installments: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026.
CACI International director Ryan D. McCarthy reported the vesting and settlement of restricted stock units into common stock. On January 14, 2026, 84 Restricted Stock Units (RSUs) converted into 84 shares of CACI common stock at a reported price of $0.00 per share, reflecting a routine equity award vesting.
These RSUs were part of a 338-unit grant awarded on October 17, 2025, scheduled to vest in four tranches: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. After this transaction, McCarthy directly beneficially owned 2,153 shares of CACI common stock and 254 RSUs, all reported as directly held.
CACI International Inc. director reports stock sale
A director of CACI International Inc. (CACI), William L. Jews, reported selling 3,000 shares of CACI common stock on 12/10/2025. The sale was reported at a price of $585.82 per share. After this transaction, he beneficially owns 3,384 CACI common shares in direct ownership. The filing is a standard Form 4 insider transaction report and does not include any derivative securities activity.
CACI International (CACI) Chief Financial Officer Jeffrey D. MacLauchlan reported equity award vesting and related tax withholdings on 11/01/2025. He acquired 1,101 shares upon vesting of restricted stock units and 5,072 shares upon vesting of performance RSUs (both shown with code M). To cover taxes, the issuer withheld 541 shares and 2,488 shares at $562.25 per share (code F). Following these transactions, his directly held stake was 7,475 shares.
Footnotes state the RSUs were granted on November 1, 2022 and vest one-third per year over three years, while the PRSUs vested on the third anniversary based on a three‑year performance measure.
CACI International (CACI) filed a Form 4 reporting that director Scott Morrison received a grant of 338 Restricted Stock Units (RSUs) on October 16, 2025. The RSUs vest in four tranches during 2026: 84 shares on January 14, 84 shares on April 14, 85 shares on July 13, and 85 shares on October 11. Following the reported transaction, 338 derivative securities were beneficially owned on a direct basis. This filing reflects routine director equity compensation and a defined vesting schedule.
CACI International Inc. (CACI) — Form 4 insider activity: Officer Eric Blazer (SVP, Corp. Controller & CAO) reported equity transactions on 10/16/2025. He acquired 98 shares of CACI common stock via the conversion of previously granted restricted stock units (Transaction Code M). To cover taxes, 30 shares were disposed at $518.23 (Code F).
Following these transactions, Blazer directly beneficially owned 180 shares. The filing also shows 99 restricted stock units remaining beneficially owned after the reported activity. The RSUs were originally granted on October 16, 2023 and vest in three equal annual installments.
CACI International Inc. director William L. Jews reported a grant of 338 restricted stock units (RSUs) on October 16, 2025. The RSUs vest as follows: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Following the grant, 338 RSUs were reported as directly owned.
CACI International (CACI) reported an insider equity award. Director Debora A. Plunkett filed a Form 4 showing an acquisition of 338 Restricted Stock Units (RSUs) on October 16, 2025. The RSUs are scheduled to vest as follows: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. Following the reported transaction, the filing lists 338 derivative securities beneficially owned with direct (D) ownership.
CACI International (CACI) director Susan M. Gordon reported an equity award on Form 4: a grant of 338 restricted stock units on October 16, 2025.
The RSUs vest in four tranches: 84 shares on January 14, 2026; 84 shares on April 14, 2026; 85 shares on July 13, 2026; and 85 shares on October 11, 2026. Following the grant, 338 derivative securities were beneficially owned, held directly.
CACI International Inc. reported a Form 4 showing Director Philip O. Nolan was granted 338 Restricted Stock Units (RSUs) on October 16, 2025 (transaction code A). The RSUs vest in four tranches during 2026: 84 on January 14, 84 on April 14, 85 on July 13, and 85 on October 11. Following the reported transaction, 338 derivative securities were beneficially owned, with ownership listed as Direct.
CACI International Inc. (CACI) reported a Form 4 for Director and Chair of the Board Lisa Disbrow. On October 16, 2025, she was granted 53 shares of CACI common stock as part of her annual retainer and 492 Restricted Stock Units (RSUs).
The RSUs vest in four equal tranches of 123 shares on January 14, 2026, April 14, 2026, July 13, 2026, and October 11, 2026. Following the grant, she beneficially owned 1,987 CACI shares directly, and 492 RSUs as derivative securities.
CACI International Inc. (CACI) director Stanton D. Sloane reported an equity award on a Form 4. On October 16, 2025, he acquired 338 Restricted Stock Units (RSUs), listed as derivative securities tied to CACI common stock.
The RSUs vest in four installments during 2026: 84 shares on January 14, 84 shares on April 14, 85 shares on July 13, and 85 shares on October 11. Following this grant, the filing shows 338 derivative securities beneficially owned, held directly.
This is a routine director compensation grant disclosed under Section 16, with a defined vesting schedule that spreads delivery over the 2026 calendar year.
CACI International Inc. disclosed a Form 4 showing Director Charles L. Szews received 338 Restricted Stock Units (RSUs) on October 16, 2025.
The award vests in four installments during 2026: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. The filing lists the RSUs in Table II as acquired and directly owned, with 338 derivative securities beneficially owned following the transaction.
This is a routine equity compensation grant to a director and does not indicate cash proceeds to the company.
CACI International (CACI) reported an insider equity award. Director Ryan D. McCarthy received 338 Restricted Stock Units on October 16, 2025. These RSUs convert into shares of CACI common stock as they vest: 84 on January 14, 2026; 84 on April 14, 2026; 85 on July 13, 2026; and 85 on October 11, 2026.
The filing shows the grant as an acquisition of derivative securities with direct ownership. RSUs typically represent a form of equity compensation that settles in stock upon vesting, aligning directors’ interests with long-term shareholder value.
CACI International Inc. (CACI) reported an insider transaction on a Form 4. Director Philip O. Nolan acquired 83 shares of CACI common stock on 10/12/2025 via settlement of restricted stock units, noted with transaction code M. After this transaction, he beneficially owned 2,069 shares directly. These RSUs were part of a 331‑unit grant from 10/17/2024 with scheduled vesting of 82 shares on 1/15/2025, 83 shares on 4/15/2025, 83 shares on 7/14/2025, and 83 shares on 10/12/2025.
CACI International (CACI) director Stanton D. Sloane reported the vesting and settlement of 83 Restricted Stock Units on October 12, 2025, resulting in the acquisition of 83 shares of CACI common stock (transaction code M).
Following this transaction, Sloane beneficially owns 859 shares, held directly. The RSUs were part of a 331-unit grant made on October 17, 2024, scheduled to vest in four tranches: 82 shares on January 15, 2025; 83 on April 15, 2025; 83 on July 14, 2025; and 83 on October 12, 2025.
CACI International Inc. (CACI) reported an insider equity change by director Debora A. Plunkett. On October 12, 2025, 83 shares of CACI common stock were acquired via an RSU vesting event (transaction code M). Following this transaction, Ms. Plunkett beneficially owned 2,564 shares, held directly.
The activity relates to a prior grant of 331 Restricted Stock Units awarded on October 17, 2024, with scheduled vesting as follows: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025.
CACI International Inc.: Director Ryan D. McCarthy reported the vesting and settlement of 83 restricted stock units into CACI common stock on October 12, 2025 (Transaction Code M). Following this transaction, he beneficially owned 2,069 shares directly.
The RSUs were granted on October 17, 2024 (331 total) with a vesting schedule of 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025.
CACI International (CACI) director Scott Morrison reported the vesting and settlement of restricted stock units into common stock. On 10/12/2025, a transaction coded M converted RSUs into 83 shares of CACI common stock. Following the transaction, Morrison beneficially owns 331 shares directly.
The activity reflects the final tranche of a previously disclosed 331 RSU grant made on October 17, 2024, which vested in scheduled installments across 2025, concluding with 83 shares on October 12, 2025.
CACI International (CACI) reported an insider equity change by Director William L. Jews. On October 12, 2025, 83 shares of CACI common stock were acquired through the conversion of vested RSUs (Code M), increasing his direct holdings to 6,384 shares.
The transaction reflects the final tranche from a 331 RSU grant awarded on October 17, 2024, which vested in installments: 82 shares on January 15, 2025; 83 shares on April 15, 2025; 83 shares on July 14, 2025; and 83 shares on October 12, 2025.
CACI International Inc. (CACI): Director Charles L. Szews reported the settlement of 83 shares of CACI common stock on 10/12/2025 via the conversion (Code M) of restricted stock units. Following this transaction, he beneficially owns 331 shares, held directly.
The 83-share vesting represents the final tranche of a 331 RSU grant awarded on 10/17/2024, which vested as 82 shares on 01/15/2025, 83 on 04/15/2025, 83 on 07/14/2025, and 83 on 10/12/2025.